Live: Tesla Q2 Earnings Call 2026 (TSLA)
Overall Thesis
Tesla achieved record Q2 2026 deliveries with strong Model Y demand, high FSD adoption rates, and ambitious expansion plans across energy, manufacturing, and robotaxi initiatives.
Narratives
Tesla's Q2 2026 earnings call highlighted record Q2 vehicle deliveries, a surging FSD attach rate (55% in North America), and continued robotaxi expansion to seven US markets with an impeccable safety record over 380,000 unsupervised miles. Management flagged a major, multi-year CapEx cycle (over $25 billion this year, growing for 2-3 more years) spanning Optimus, robotaxi, a semiconductor Terafab, and solar manufacturing, which is compressing near-term automotive and energy margins and pushing free cash flow negative. Host Rob Maurer remains fundamentally bullish on the long-term robotaxi/FSD/Optimus thesis while acknowledging the market's negative reaction to margin compression and sustained heavy CapEx.
Key Arguments
- FSD attach rate reached 55% of North American deliveries, suggesting customers are increasingly buying the car as a vehicle for FSD rather than the reverse
- Robotaxi fleet has driven over 380,000 unsupervised miles across six cities with zero notable safety incidents, and is growing at a double-digit weekly compounding rate
- V15 FSD software, partially deployed in the robotaxi fleet, is expected to unlock the next leg of unsupervised mileage growth
- Record Q2 deliveries with sequential growth of 60% (Americas), 27% (APAC), and 12% (EMEA), and the largest order backlog since 2023
- Company is in the midst of what management calls the most ambitious infrastructure buildout in history, spanning Optimus, Terafab, Megapack, solar cell production, and lithium/cathode refining
Predictions (1)
Hedges & Caveats
- Forward-looking statements based on predictions and expectations that could differ materially due to risks and uncertainties
- SEC filing disclosures referenced for risk factors
- Cautious approach noted regarding robotaxi safety and accident prevention
- Acknowledgment of regulatory approval dependencies for FSD in different countries